Market Access Changing Faces: Agency, consultancy, and investor hires for ... Just a quick write-up this month for agency, consultancy, and investor hires.
Sales & Marketing Changing Faces – Agency, consultancy, and investor hires fro... Welcome back to Changing Faces for the month of July.
Sales & Marketing Changing Faces May-June 2024: Agency, consultancy, and inves... For a super-sized hires round-up, our list of hires in the agency and consultancy world for May and June is surprisingly concise.
Sales & Marketing Changing Faces: Agency, consultancy, and investor hires from... With apologies for the lateness, we didn’t want to miss the opportunity to acknowledge the many moves in the pharma agency space in April.
Sales & Marketing Changing Faces: Agency, consultancy, and investor hires from... Another light month in March on the agency and investor side, but there are a few appointments worth noting.
Sales & Marketing Changing Faces: Agency, consultancy, and investor hires from... We had a light month for hires in February in the agency, consultancy, and investor worlds. But we did have a few notable job changes cross the wire.
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
